DE60044514D1 - Isolierung von biologischen Modulatoren aus Bibliotheken mit biologisch vielvältigen Genfragmenten - Google Patents
Isolierung von biologischen Modulatoren aus Bibliotheken mit biologisch vielvältigen GenfragmentenInfo
- Publication number
- DE60044514D1 DE60044514D1 DE60044514T DE60044514T DE60044514D1 DE 60044514 D1 DE60044514 D1 DE 60044514D1 DE 60044514 T DE60044514 T DE 60044514T DE 60044514 T DE60044514 T DE 60044514T DE 60044514 D1 DE60044514 D1 DE 60044514D1
- Authority
- DE
- Germany
- Prior art keywords
- libraries
- isolation
- activity
- gene fragments
- diverse gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
- C12N15/1027—Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13271199P | 1999-05-05 | 1999-05-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60044514D1 true DE60044514D1 (de) | 2010-07-15 |
Family
ID=22455261
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60044514T Expired - Lifetime DE60044514D1 (de) | 1999-05-05 | 2000-05-05 | Isolierung von biologischen Modulatoren aus Bibliotheken mit biologisch vielvältigen Genfragmenten |
DE60026695T Expired - Lifetime DE60026695T2 (de) | 1999-05-05 | 2000-05-05 | ISOLIERUNG VON BIOLOGISCHEN MODULATOREN AUS BIBIOTHEKEN MIT BIOLOGISCH VIELFäLTIGEN GENFRAGMENTEN |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60026695T Expired - Lifetime DE60026695T2 (de) | 1999-05-05 | 2000-05-05 | ISOLIERUNG VON BIOLOGISCHEN MODULATOREN AUS BIBIOTHEKEN MIT BIOLOGISCH VIELFäLTIGEN GENFRAGMENTEN |
Country Status (10)
Country | Link |
---|---|
US (7) | US6994982B1 (de) |
EP (4) | EP2230303B1 (de) |
AT (2) | ATE469979T1 (de) |
AU (6) | AU771534B2 (de) |
CA (2) | CA2721199A1 (de) |
DE (2) | DE60044514D1 (de) |
DK (1) | DK2230303T3 (de) |
ES (2) | ES2260009T3 (de) |
NZ (1) | NZ515329A (de) |
WO (1) | WO2000068373A1 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7803765B2 (en) | 1999-05-05 | 2010-09-28 | Phylogica Limited | Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom |
US7270969B2 (en) * | 1999-05-05 | 2007-09-18 | Phylogica Limited | Methods of constructing and screening diverse expression libraries |
AT410798B (de) * | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
FR2824844B1 (fr) * | 2001-05-18 | 2003-09-19 | Genoway | Procede de clonage par double selection et vecteurs pour ce procede |
GB0126887D0 (en) * | 2001-11-08 | 2002-01-02 | Univ London | Method for producing and identifying soluble protein domains |
CN100422334C (zh) * | 2001-11-27 | 2008-10-01 | 内克西特股份有限公司 | 秀丽新杆线虫中真核生物蛋白质和核酸分子的生产 |
US20050153304A1 (en) * | 2003-04-10 | 2005-07-14 | Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | Multivariate profiling of complex biological regulatory pathways |
US20110218118A1 (en) * | 2004-06-03 | 2011-09-08 | Phylogica Limited | Peptide modulators of cellular phenotype and bi-nucleic acid fragment library |
AU2007218045B2 (en) | 2006-02-20 | 2011-11-10 | Phylogica Limited | Method of constructing and screening libraries of peptide structures |
WO2008034161A1 (en) | 2006-09-19 | 2008-03-27 | Phylogica Limited | Neuroprotective peptide inhibitors of ap-1 signaling and uses therefor |
FR2910493B1 (fr) * | 2006-12-20 | 2012-12-14 | Bio Modeling Systems Ou Bmsystems | Procede de diversification aleatoire d'une sequence genetique permettant de preserver l'identite de certains segments internes de ladite sequence genetique |
WO2008154700A1 (en) | 2007-06-20 | 2008-12-24 | Phylogica Limited | Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ards) and clinical disorders associated with therewith |
JP6336400B2 (ja) | 2012-02-10 | 2018-06-06 | フィロジカ リミテッドPhylogica Limited | 標的タンパク質上の相互作用部位を特性決定する方法 |
EP2931293B1 (de) | 2012-12-12 | 2019-02-20 | University Of Virginia Patent Foundation | Zusammensetzungen und verfahren zur regulierung der erythropoiese |
WO2016105542A2 (en) | 2014-12-24 | 2016-06-30 | Neximmune, Inc | Nanoparticle compositions and methods for immunotherapy |
US10363299B2 (en) | 2015-02-19 | 2019-07-30 | University Of Virginia Patent Foundation | Compositions and methods for preventing and treating rhinovirus infections |
EP3371311B1 (de) | 2015-11-06 | 2021-07-21 | Orionis Biosciences BV | Bifunktionale chimäre proteine und verwendungen davon |
SG10202004259PA (en) | 2015-11-19 | 2020-06-29 | Asclepix Therapeutics Llc | Peptides with anti-angiogenic, anti-lymphangiogenic, and anti-edemic properties and nanoparticle formulations |
WO2017134305A1 (en) | 2016-02-05 | 2017-08-10 | Orionis Biosciences Nv | Bispecific signaling agents and uses thereof |
CN109069573B (zh) | 2016-03-07 | 2022-04-05 | 弗拉芒区生物技术研究所 | 结合cd20的单结构域抗体 |
WO2017194782A2 (en) | 2016-05-13 | 2017-11-16 | Orionis Biosciences Nv | Therapeutic targeting of non-cellular structures |
WO2017194783A1 (en) | 2016-05-13 | 2017-11-16 | Orionis Biosciences Nv | Targeted mutant interferon-beta and uses thereof |
KR20190066040A (ko) | 2016-10-04 | 2019-06-12 | 아스클리픽스 테라퓨틱스, 인크. | Tie2 신호전달을 활성화시키기 위한 화합물 및 방법 |
US10738338B2 (en) | 2016-10-18 | 2020-08-11 | The Research Foundation for the State University | Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate |
ES2917000T3 (es) | 2016-10-24 | 2022-07-06 | Orionis Biosciences BV | Interferón-gamma mutante diana y usos del mismo |
KR102642385B1 (ko) | 2017-02-06 | 2024-03-04 | 오리오니스 바이오사이언시스 엔브이 | 표적화된 키메라 단백질 및 이의 용도 |
US10906985B2 (en) | 2017-02-06 | 2021-02-02 | Orionis Biosciences, Inc. | Targeted engineered interferon and uses thereof |
EP3580230A1 (de) | 2017-02-07 | 2019-12-18 | VIB vzw | Auf immunzellen gerichtete bispezifische chimäre proteine und verwendungen davon |
US11674959B2 (en) | 2017-08-03 | 2023-06-13 | The Johns Hopkins University | Methods for identifying and preparing pharmaceutical agents for activating Tie1 and/or Tie2 receptors |
AU2019215440A1 (en) | 2018-02-05 | 2020-08-27 | Orionis Biosciences, Inc. | Fibroblast binding agents and use thereof |
CA3129317A1 (en) | 2019-02-15 | 2020-08-20 | Integral Molecular, Inc. | Antibodies comprising a common light chain and uses thereof |
JP2022521723A (ja) | 2019-02-15 | 2022-04-12 | インテグラル・モレキュラー・インコーポレイテッド | クローディン6抗体及びその使用 |
GB202004514D0 (en) | 2020-03-27 | 2020-05-13 | Inst De Medicina Molecular Joaeo Lobo Antunes | Treatment of Immunosuppressive Cancer |
WO2024008755A1 (en) | 2022-07-04 | 2024-01-11 | Vib Vzw | Blood-cerebrospinal fluid barrier crossing antibodies |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
ATE277179T1 (de) | 1990-02-01 | 2004-10-15 | Dade Behring Marburg Gmbh | HERSTELLUNG UND VERWENDUNG VON GENBANKEN MENSCHLICHER ANTIKÖRPER (ßHUMAN-ANTIKÖRPER- BIBLIOTHEKENß) |
DK0564531T3 (da) | 1990-12-03 | 1998-09-28 | Genentech Inc | Berigelsesfremgangsmåde for variantproteiner med ændrede bindingsegenskaber |
US5723287A (en) | 1992-09-22 | 1998-03-03 | Medical Research Council | Recombinant viruses displaying a nonviral polypeptide on their external surface |
US5470953A (en) | 1993-12-23 | 1995-11-28 | Icos Corporation | Human β2 integrin α subunit |
US5516637A (en) | 1994-06-10 | 1996-05-14 | Dade International Inc. | Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage |
US5883074A (en) | 1995-02-08 | 1999-03-16 | Microcide Pharmaceuticals, Inc. | Potentiators of antibacterial agents |
WO1996040979A1 (en) | 1995-06-07 | 1996-12-19 | Microcide Pharmaceuticals, Inc. | Methods for evaluation of antimicrobial targets |
US6238884B1 (en) * | 1995-12-07 | 2001-05-29 | Diversa Corporation | End selection in directed evolution |
US20030215798A1 (en) * | 1997-06-16 | 2003-11-20 | Diversa Corporation | High throughput fluorescence-based screening for novel enzymes |
US5783431A (en) * | 1996-04-24 | 1998-07-21 | Chromaxome Corporation | Methods for generating and screening novel metabolic pathways |
US5763239A (en) | 1996-06-18 | 1998-06-09 | Diversa Corporation | Production and use of normalized DNA libraries |
US5955275A (en) * | 1997-02-14 | 1999-09-21 | Arcaris, Inc. | Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes |
US5846722A (en) * | 1996-10-16 | 1998-12-08 | Terrapin Technologies, Inc. | System to detect small molecule/peptide interaction |
GB9703406D0 (en) | 1997-02-19 | 1997-04-09 | Chiron Spa | Expression of heterologous proteins |
US5843698A (en) * | 1997-04-30 | 1998-12-01 | Universal Ventures | Deleteriously affecting members of a target species by exposure to a component of symbiont or food source of an adjoiner species that is symbiotic with the target species |
US6083715A (en) | 1997-06-09 | 2000-07-04 | Board Of Regents, The University Of Texas System | Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells |
US6583275B1 (en) * | 1997-07-02 | 2003-06-24 | Genome Therapeutics Corporation | Nucleic acid sequences and expression system relating to Enterococcus faecium for diagnostics and therapeutics |
US6610495B1 (en) * | 1998-01-09 | 2003-08-26 | Tvw Telethon Intstitute For Child Health Research | Method for detecting proteinaceous inhibitors of protein-protein or DNA-protein interactions |
WO1999039210A1 (en) * | 1998-01-29 | 1999-08-05 | Miller, Samuel | High density arrays for proteome analysis and methods and compositions therefor |
US6316223B1 (en) | 1998-03-30 | 2001-11-13 | Rigel Pharmaceuticals, Inc. | Mammalian protein interaction cloning system |
US6190908B1 (en) | 1998-08-12 | 2001-02-20 | The Scripps Research Institute | Modulation of polypeptide display on modified filamentous phage |
US6287825B1 (en) * | 1998-09-18 | 2001-09-11 | Molecular Staging Inc. | Methods for reducing the complexity of DNA sequences |
US6720139B1 (en) * | 1999-01-27 | 2004-04-13 | Elitra Pharmaceuticals, Inc. | Genes identified as required for proliferation in Escherichia coli |
US6074815A (en) * | 1999-03-08 | 2000-06-13 | Universal Ventures | Selection of test species for testing to identify components thereof that deleteriously affect a target species member |
US7270969B2 (en) | 1999-05-05 | 2007-09-18 | Phylogica Limited | Methods of constructing and screening diverse expression libraries |
US6150127A (en) * | 1999-11-30 | 2000-11-21 | Universal Ventures | Causing a desirable change in a behavior pattern |
EP1274720A4 (de) * | 2000-04-12 | 2004-08-18 | Human Genome Sciences Inc | Albumin enthaltende fusionsproteine |
CN1447862A (zh) | 2000-07-12 | 2003-10-08 | 加州理工学院 | 一种由蛋白质的一级结构序列确定蛋白质三维结构的方法 |
-
2000
- 2000-05-05 CA CA2721199A patent/CA2721199A1/en not_active Abandoned
- 2000-05-05 AT AT06003767T patent/ATE469979T1/de active
- 2000-05-05 EP EP10005416A patent/EP2230303B1/de not_active Expired - Lifetime
- 2000-05-05 DE DE60044514T patent/DE60044514D1/de not_active Expired - Lifetime
- 2000-05-05 NZ NZ515329A patent/NZ515329A/en not_active IP Right Cessation
- 2000-05-05 US US09/568,229 patent/US6994982B1/en not_active Expired - Lifetime
- 2000-05-05 AU AU42759/00A patent/AU771534B2/en not_active Ceased
- 2000-05-05 ES ES00922330T patent/ES2260009T3/es not_active Expired - Lifetime
- 2000-05-05 AT AT00922330T patent/ATE320486T1/de active
- 2000-05-05 DE DE60026695T patent/DE60026695T2/de not_active Expired - Lifetime
- 2000-05-05 EP EP06003767A patent/EP1696038B1/de not_active Expired - Lifetime
- 2000-05-05 EP EP06002104A patent/EP1696037A3/de not_active Withdrawn
- 2000-05-05 ES ES10005416T patent/ES2402878T3/es not_active Expired - Lifetime
- 2000-05-05 CA CA2372464A patent/CA2372464C/en not_active Expired - Lifetime
- 2000-05-05 EP EP00922330A patent/EP1179059B1/de not_active Expired - Lifetime
- 2000-05-05 WO PCT/AU2000/000414 patent/WO2000068373A1/en active IP Right Grant
- 2000-05-05 DK DK10005416.2T patent/DK2230303T3/da active
-
2004
- 2004-02-20 AU AU2003302489A patent/AU2003302489B8/en not_active Ceased
-
2005
- 2005-08-04 US US11/198,436 patent/US20050287580A1/en not_active Abandoned
-
2006
- 2006-01-10 AU AU2006200082A patent/AU2006200082B2/en not_active Ceased
-
2007
- 2007-08-06 US US11/890,714 patent/US20080139401A1/en not_active Abandoned
-
2008
- 2008-02-19 AU AU2008200790A patent/AU2008200790A1/en not_active Abandoned
-
2009
- 2009-12-24 AU AU2009251209A patent/AU2009251209B2/en not_active Ceased
- 2009-12-30 US US12/650,351 patent/US20100227777A1/en not_active Abandoned
-
2010
- 2010-10-20 US US12/908,828 patent/US20110092386A1/en not_active Abandoned
-
2011
- 2011-01-04 AU AU2011200020A patent/AU2011200020A1/en not_active Withdrawn
- 2011-12-30 US US13/341,788 patent/US20120214709A1/en not_active Abandoned
-
2015
- 2015-07-09 US US14/795,760 patent/US20150344875A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE469979T1 (de) | Isolierung von biologischen modulatoren aus bibliotheken mit biologisch vielvältigen genfragmenten | |
NO883592L (no) | Enzym. | |
ATE313625T1 (de) | ßFUNCTIONAL GENOMICSß UNTER VERWENDUNG VON ZINK FINGER PROTEINEN | |
DE60303591D1 (de) | System und methode zur herstellung von rekombinanten, glykosylierten protein in prokaryontischen wirtszellen | |
ATE551352T1 (de) | Peptidakzeptorbindungsverfahren | |
DE69932813D1 (de) | Nukleinsäurebindungsproteine | |
DE68928467D1 (de) | RNS-Katalysator zur Spaltung von spezifischen RNS-Sequenzen | |
DE60213803D1 (en) | Happier mapping | |
DE60206885D1 (de) | Agarase und gen dafür | |
DE69831500T2 (de) | Humane checkpointkinase, hcds1, zusammensetzungen und verfahren | |
EE200100040A (et) | Meetod raku fenotüüpi muutva modulaatori identifitseerimiseks ja valmistamiseks, sihtmärkbiomolekulide eraldamiseks ja/või samastamiseks ning meditsiinitoote arendamiseks ja valmistamiseks | |
ATE371732T1 (de) | Verfahren zur genexpression | |
EP1369477A4 (de) | KONSTRUKTIONSVERFAHREN FÜR EIN cDNA-TAG ZUR IDENTIFIZIERUNG EINES EXPRIMIERTEN GENS UND VERFAHREN ZUR ANALYSE DER GENEXPRESSION | |
SE9403805D0 (sv) | Method of preparing oligonucleotide probes or primers, vector therefor and use thereof | |
DE59901930D1 (de) | Expressionssystem zur produktion von proteinen | |
WO2003043580A3 (en) | Methods for identifying and validating potential drug targets | |
DK1180138T3 (da) | Polynukleotidmotor, motorsystem, fremstilling og anvendelse deraf | |
DK1123396T3 (da) | Minimale promotorer og anvendelser deraf |